Post-earnings recap
Reported
Tue, Oct 15, 2024
EPS actual
$0.02
EPS est.
—
EPS surprise
—
1-day move
-0.41%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytoDyn Inc. reported an EPS of $0.02, but no revenue figures were disclosed. The stock reacted negatively, declining by 0.41%. The lack of guidance and details from the earnings call may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.02 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.